TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients
Dr. Berwanger and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.
Andexanet alfa: Rapid reversal of Factor Xa inhibitors
On Monday, March 12th at ACC 2018 in Orlando, Florida, an interim analysis from the ongoing ANNEXA-4 study demonstrated that the first- in-class reversal drug for direct and indirect factor…
Using High Sensitivity Troponin T in Ruling Out Acute Coronary Syndrome
High sensitivity troponin T (hsTnT) can be a reliable tool for excluding acute coronary syndrome (ACS) in very low-risk patients, according to a recent study published in the Journal of…
ACC 2018 – Wrap Up from a Pacific Rim Perspective
Dr. Daniel Scherer and Dr. Phil Aylward Discuss Subscribe on iTunes or Google Play.
ACC 2018 – Wrap Up from a Canadian Perspective
Dr. John Eikelboom Presents Subscribe on iTunes or Google Play.
CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients
Dr. Ridker and Dr. C. Michael Gibson Subscribe on iTunes or Google Play.
ACC 2018 Daily Wrap-Up – March 11, 2018
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss Subscribe on iTunes or Google Play.
ACC 2018 Daily Wrap-Up – March 10, 2018
Dr. Kirtane and Dr. Gibson Discuss Subscribe on iTunes or Google Play.